{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:17:03Z","timestamp":1792289823502,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.resinv.2024.09.003","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T08:18:31Z","timestamp":1725956311000},"page":"1044-1050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Analysis of anticholinergic drugs associated with aspiration pneumonia using the Japanese adverse drug event report database: Supplementary insights from a scoping review"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-7712","authenticated-orcid":false,"given":"Akihito","family":"Ueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-4615","authenticated-orcid":false,"given":"Kanji","family":"Nohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Obara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1343-5167","authenticated-orcid":false,"given":"Shinichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2024.09.003_bib1","year":"2024","journal-title":"The JRS guidelines for the management of pneumonia in adults"},{"key":"10.1016\/j.resinv.2024.09.003_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.294.6.716","article-title":"Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance","volume":"294","author":"Boyd","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2024.09.003_bib3","year":"2015","journal-title":"Guidelines for medical treatment and its safety in the elderly"},{"key":"10.1016\/j.resinv.2024.09.003_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2209736","article-title":"Association between anticholinergic medication uses and the risk of pneumonia in elderly adults: a meta-analysis and systematic review","volume":"55","author":"Wu","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.resinv.2024.09.003_bib5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/ggi.13454","article-title":"Assessment of aspiration pneumonia using the anticholinergic Risk Scale","volume":"18","author":"Kose","year":"2018","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.resinv.2024.09.003_bib7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.resinv.2024.09.003_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.resinv.2024.09.003_bib9","first-page":"135","article-title":"Basic dos and don\u2019ts in applying signal detection methods to spontaneous reporting systems databases","volume":"21","author":"Urushihara","year":"2020","journal-title":"Jpn. J Drug Inform"},{"key":"10.1016\/j.resinv.2024.09.003_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"10.1016\/j.resinv.2024.09.003_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1517\/14740338.2016.1165664","article-title":"Anticholinergics: theoretical and clinical overview","volume":"15","author":"Nishtala","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.resinv.2024.09.003_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/YIC.0000000000000162","article-title":"Clozapine usage increases the incidence of pneumonia compared with risperidone and the general population: a retrospective comparison of clozapine, risperidone, and the general population in a single hospital over 25 months","volume":"32","author":"Stoecker","year":"2017","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.resinv.2024.09.003_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/NDT.S2367","article-title":"Serum substance P levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics","volume":"4","author":"Nagamine","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.resinv.2024.09.003_bib14","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1378\/chest.103.5.1636b","article-title":"Risk of aspiration pneumonia in the elderly","volume":"103","author":"Nakazawa","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.09.003_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40263-019-00693-5","article-title":"Mortality risk associated with haloperidol use compared with other antipsychotics: an 11-year population-based propensity-score-matched cohort study","volume":"34","author":"Lao","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.resinv.2024.09.003_bib16","series-title":"Guidelines for family physicians on the use of psychotropic drugs in response to BPSD","first-page":"3","author":"Ministry of Health","year":"2013"},{"key":"10.1016\/j.resinv.2024.09.003_bib17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/pds.3882","article-title":"Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly","volume":"24","author":"Mehta","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.resinv.2024.09.003_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/acps.13532","article-title":"A case-control study of antipsychotic use and pneumonia-related mortality in the United Kingdom","volume":"147","author":"Copeland","year":"2023","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.resinv.2024.09.003_bib19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jagp.2020.01.193","article-title":"Risk of mortality associated with atypical antipsychotic use: a national cohort study of older adults with depression and Parkinson's disease","volume":"28","author":"Chekani","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.resinv.2024.09.003_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpsychires.2019.07.005","article-title":"Risk of pneumonia associated with atypical antipsychotic use in nursing home residents with Parkinson's disease","volume":"117","author":"Chekani","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.resinv.2024.09.003_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.2373-18","article-title":"Management of dysphagia in patients with Parkinson's disease and related disorders","volume":"59","author":"Umemoto","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2024.09.003_bib22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/jgs.13932","article-title":"Anticholinergic medication use and risk of pneumonia in elderly adults: a nested case-control study","volume":"64","author":"Chatterjee","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.resinv.2024.09.003_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/jgs.13327","article-title":"Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study","volume":"63","author":"Paul","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.resinv.2024.09.003_bib24","first-page":"595","article-title":"Pharmacological considerations in antipsychotic drug selection for prevention of drug-induced dysphagia","volume":"75","author":"Koshiishi","year":"2020","journal-title":"Pharmazie"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524001394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524001394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:51:22Z","timestamp":1732092682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534524001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2212534524001394"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2024.09.003","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of anticholinergic drugs associated with aspiration pneumonia using the Japanese adverse drug event report database: Supplementary insights from a scoping review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2024.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}